Please login to the form below

Not currently logged in
Email:
Password:

drug choices

This page shows the latest drug choices news and features for those working in and with pharma, biotech and healthcare.

Drug of choice

Drug of choice

Drug of choice. Can patients make the right decisions? It seems rather obvious to me that the choices one makes are limited and governed by the choices one has. ... Who knows best? We are all products of the choices we are given.

Latest news

  • Connected Healthcare Connected Healthcare

    More than half (52%) felt their patients are better informed about drug choices and treatment options, and 58% agreed that their patients have greater expectations of their care.

  • NHS explains cancer drug findings

    NHS explains cancer drug findings. NHS Choices clarifies published research which claims its possible to identify chemicals that specifically kill cancer stem cells. ... that kills the deadly stem cells which drive the growth of tumours", NHS Choices has

  • Getting the inside track

    Getting the inside track. Understanding GPs' drug therapy choices can assist in identifying potential new markets. ... While Diovan was the only hypertension drug known by the majority of GPs (87 per cent knew a lot or a little about the drug), six drugs

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • How Can We Make Payer Communications Really Sing?

    What choices are available? What is the decision-making context? What stories are being built? ... In addition, access decisions involving many steps, stages and drug choices, very quickly bring extremely complex calculations.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics